Evidence map›Paper›PMID 41129238›Full record

ArticleThe Journal of clinical investigation2026

T cell acute lymphoblastic leukemia exploits a neural proinflammatory pathway to colonize the meninges.

Nitesh D Sharma, Esra'a Keewan, Wojciech Ornatowski, Silpita Paul, Monique Nysus, Christopher C Barnett, Julie Wolfson, Quiteria Jacquez, Bianca L Myers, Huining Kang and 11 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Nitesh D SharmaDepartment of Cell Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Esra'a KeewanDepartment of Pediatrics, University of New Mexico, Albuquerque, New Mexico, USA.
Wojciech OrnatowskiDepartment of Cell Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Silpita PaulDepartment of Cell Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Monique NysusDepartment of Pediatrics, University of New Mexico, Albuquerque, New Mexico, USA.
Christopher C BarnettDepartment of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Julie WolfsonDepartment of Pediatrics, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Quiteria JacquezCollege of Nursing.
Bianca L MyersDepartment of Neurosciences, and.
Huining KangDepartment of Internal Medicine, University of the New Mexico, Albuquerque, New Mexico, USA.
Katherine E ZychowskiCollege of Nursing.
Stuart S WinterChildren's Minnesota, Minneapolis, Minnesota, USA.
Mignon L LohSeattle Children's Research Institute and the Department of Pediatrics, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA.
Stephen P HungerDepartment of Pediatrics and the Center for Childhood Cancer Research, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Eliseo F CastilloDepartment of Internal Medicine, Division of Gastroenterology and Hepatology, University of New Mexico, Albuquerque, New Mexico, USA.
Tom TaghonCancer Research Institute Ghent, Ghent, Belgium.
Christina HalseyWolfson Wohl Cancer Research Centre, College of Medical Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Tou Yia VueDepartment of Neurosciences, and.
Nicholas JonesInstitute of Life Science, Swansea University Medical School, Swansea, Wales, United Kingdom.
Panagiotis NtziachristosCancer Research Institute Ghent, Ghent, Belgium.
Ksenia Matlawska-WasowskaDepartment of Cell Developmental and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, USA.

Funding

XRAY CRYSTALLOGRAPHYP30CA013148 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Omer Jamy · 1985 to 2026
$165.9M
WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
Support for Human Specimen Banking in NCI-Supported Cancer Clinical TrialsU24CA114766 · NCI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI RAMIREZ MILAN, NILSA DEL CARMEN · 2005 to 2014
$14.5M
The roles of SOCS5 in T-ALL migration and tissue infiltrationR01CA237165 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI MATLAWSKA-WASOWSKA, KSENIA · 2019 to 2023
$1.7M
Role of CXCR3-CXCL10 signaling in T-ALL CNS diseaseR01CA282701 · NCI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Ksenia Matlawska-Wasowska · 2024 to 2026
$1.3M
NCI NIH HHS P30 CA013148NCI NIH HHS P30 CA118100NCI NIH HHS R01 CA237165NCI NIH HHS R01 CA282701NCI NIH HHS U24 CA114766
6 · The paper itself

Abstract

Infiltration of T cell acute lymphoblastic leukemia (T-ALL) into the meninges worsens prognosis, underscoring the need to understand mechanisms driving meningeal involvement. Here, we show that T-ALL cells expressing CXCR3 exploit normal T cell function to infiltrate the inflamed meninges. CXCR3 deletion hampered disease progression and extramedullary dissemination by reducing leukemic cell proliferation and migration. Conversely, forced expression of CXCR3 facilitated T-ALL trafficking to the meninges. We identified the ubiquitin-specific protease 7 as a key regulator of CXCR3 protein stability in T-ALL. Furthermore, we discovered elevated levels of CXCL10, a CXCR3 ligand, in the cerebrospinal fluid from patients with T-ALL and leukemia-bearing mice. Our studies demonstrate that meningeal stromal cells, specifically pericytes and fibroblasts, induce CXCL10 expression in response to leukemia and that loss of CXCL10 attenuated T-ALL influx into the meninges. Moreover, we report that leukemia-derived proinflammatory cytokines, TNF-α, IL-27, and IFN-γ, induced CXCL10 in the meningeal stroma. Pharmacological inhibition or deletion of CXCR3 or CXCL10 reduced T-ALL cell migration and adhesion to meningeal stromal cells. Finally, we reveal that CXCR3 and CXCL10 upregulated VLA-4/VCAM-1 signaling, promoting cell-cell adhesion and thus T-ALL retention in the meninges. Our findings highlight the pivotal role of CXCR3-CXCL10 signaling in T-ALL progression and meningeal colonization.

Indexed as

Meningeal NeoplasmsMeningesNeoplasm ProteinsPrecursor T-Cell Lymphoblastic Leukemia-LymphomaAnimalsCell MovementChemokine CXCL10HumansLeukemic InfiltrationMiceMice, KnockoutReceptors, CXCR3Signal TransductionChemokine CXCL10CXCL10 protein, humanCxcl10 protein, mouseCXCR3 protein, humanCxcr3 protein, mouseNeoplasm ProteinsReceptors, CXCR3Cell migration/adhesionChemokinesInflammationLeukemiasOncology

Identifiers

PMID41129238
PMCPMC12807478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.